Showing 17,061 - 17,080 results of 66,741 for search '(( 50 ((((a decrease) OR (we decrease))) OR (mean decrease)) ) OR ( 5 c decrease ))', query time: 1.37s Refine Results
  1. 17061

    Identification and Characterization of a Leoligin-Inspired Synthetic Lignan as a TGR5 Agonist by Alexander F. Perhal (20946742)

    Published 2025
    “…In this study, we identify the natural product-inspired synthetic structural analogue of leoligin, LT-188A (<b>1</b>), as a novel nonsteroidal TGR5 agonist. LT-188A (<b>1</b>) induced cyclic adenosine monophosphate (cAMP) accumulation and cAMP response element (CRE)-dependent luciferase activity in a concentration- and TGR5-dependent manner. …”
  2. 17062

    Targeting Acidic Mammalian chitinase Is Effective in Animal Model of Asthma by Marzena Mazur (4761027)

    Published 2017
    “…Rational design, guided by X-ray analysis of several inhibitors bound to human chitotriosidase (hCHIT1), led to the identification of compound <b>7f</b> as a highly potent AMCase inhibitor (IC<sub>50</sub> values of 14 and 19 nM against human and mouse enzyme, respectively) and selective (>150× against mCHIT1) with very good PK properties. …”
  3. 17063

    Three different models explaining the role of <i>sfrp5</i> in hepatic development. by Carsten Stuckenholz (212988)

    Published 2013
    “…<b>A)</b> Wnt acts as a signaling gradient and any shift in the gradient by increasing or decreasing Sfrp5 levels misaligns the liver bud (asterisk) and pancreatic bud (black arrowhead) with mesodermal signals (red arrows). …”
  4. 17064
  5. 17065

    Flibanserin’s neuroprotective effects are 5-HT<sub>1A</sub> receptor-mediated. by Aaron S. Coyner (2889722)

    Published 2016
    “…(<b>A ii, A iii</b>) Receptor plus thicknesses, with each dot representing average right and left eye thickness from one mouse, demonstrate that both pre-treatment of BALB/c mice with WAY 100635 prior to a flibanserin injection (10 mg/kg WAY + 6 mg/kg Flibanserin, <i>green</i>) and a flibanserin injection in 5-HT<sub>1A</sub> knockout mice (5-HT1A KO + 6 mg/kg Flibanserin, <i>red</i>) significantly reduces the observed neuroprotective effects provided by a single 6 mg/kg dose of flibanserin (6 mg/kg Flibanserin, <i>blue</i>) in the <b>(A ii)</b> temporal quadrant and the <b>(A iii)</b> nasal quadrant. …”
  6. 17066

    Multivariate analysis and CSF Aβ5-40/Aβ1-34. by Niklas Mattsson (144720)

    Published 2012
    “…<p>Multivariate discriminant analysis of the CSF Aβ pattern for treatment compared with placebo in dogs treated with vehicle (N = 15), NB-C8 (N = 3 at 3 h, N = 3 at 16 h) and NB-B4 (N = 5 at 6 h) (Panels a–b). …”
  7. 17067
  8. 17068

    Kinetic analysis of inorganic phosphate transport in oocytes expressing NPT2a or co-expressing NPT2a and CFTR. by Naziha Bakouh (171145)

    Published 2012
    “…Data were fitted to the modified Hill equation. Results, as means ± SD, were as follows: the apparent K<sub>m</sub> for Na<sup>+</sup> substrate was 40.7 ± 14.6 in NPT2a-oocytes, not different from 41.8 ± 13.4 mM in NPT2a+CFTR-oocytes; IPi<sub>max</sub> was decreased by 39±7% in NPT2a+CFTR-oocytes compared to NPT2a-oocytes (P < 0.05). …”
  9. 17069

    Representative photographs of colonic claudin-5, claudin-7 and claudin-8 immunostaining in mice. by Xian-Ming Xia (340280)

    Published 2013
    “…The intensity was significantly decreased in colitis group (B), and increased when treated with AMD3100 (C). …”
  10. 17070

    FABP5 expression modulates TLR2 and TLR4 mRNA expression. by Fabienne Gally (260470)

    Published 2013
    “…<b>C.</b> TLR2 mRNA expression was decreased in cells overexpressing FABP5. …”
  11. 17071

    Galectin-1 inhibits NiV-F<sub>0</sub> endocytosis and maturation. by Omai B. Garner (245658)

    Published 2010
    “…<p><b>A</b>, Galectin-1 decreases internalization of NiV-F<sub>0</sub> from the plasma membrane. …”
  12. 17072

    ACh effects on hippocampal neurons confirm its diffusion into V1 deep layers. by Shogo Soma (429657)

    Published 2013
    “…Topical administration of ACh increased (B) or decreased (C) the number of spikes irrespective of the visual stimulus, suggesting that topically administered ACh reached the CA1 through V1 and white matter. …”
  13. 17073
  14. 17074

    Evidence for extensive anaerobic dechlorination and transformation of the pesticide chlordecone (C<sub>10</sub>Cl<sub>10</sub>O) by indigenous microbes in microcosms from Guadeloup... by Line Lomheim (1564468)

    Published 2020
    “…Observed products included monohydro-, dihydro- and trihydrochlordecone derivatives (C<sub>10</sub>Cl<sub>10-n</sub>O<sub>2</sub>H<sub>n</sub>; n = 1,2,3), as well as “open cage” C9 polychloroindene compounds (C<sub>9</sub>Cl<sub>5-n</sub>H<sub>3+n</sub> n = 0,1,2) and C10 carboxylated polychloroindene derivatives (C<sub>10</sub>Cl<sub>4-n</sub>O<sub>2</sub>H<sub>4+n</sub>, n = 0–3). …”
  15. 17075

    Image_5_CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment.TIF by Yinjiang Zhang (5030006)

    Published 2021
    “…Also, hsa-miR-4278 and hsa-miR-324-5p, two potential miRNA targets of CLEC4s, were uncovered. …”
  16. 17076
  17. 17077
  18. 17078
  19. 17079

    Limited PNGase F digestion of GP5–HA to show modification with three glycans. by Bastian Thaa (418825)

    Published 2013
    “…The number of carbohydrates cleaved by PNGase F decreases with decreasing concentration. This causes a ladder-like appearance of bands that allows counting of the total number of carbohydrates linked to GP5–HA (arrowheads). …”
  20. 17080

    Immunoblotting for CRMP1, DPYSL5, NDRG1, FSCN1 and PRDX6. by Lu Qin (124431)

    Published 2017
    “…<p>Quantification of protein levels showed increased expression of CRMP1 (A), DPYSL5 (B), NDRG1 (C) and FSCN1 (D) and decreased expression of PRDX6 (E) in brain tissue of childhood cortical dysplasia patients compared to controls. …”